Novel “SMARTer” Clinical Trial Design Improves Odds of Approval and Can Reduce Study Size By 80%: Modeling Use of a ctDNA “Optimizing Diagnostic” for Early Therapy Switching in Immuno-Oncology Trials
Preprint in medRxiv (February 2023)
The most recent citing publication is shown below. View this citation on Dimensions.